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A B S T R A C T
 
Background: Infection with human T-lymphotropic virus 1 or 2 (HTLV-1/2) is a major health 
problem. There is a public health policy defining measures for state hematology and 
hemotherapy centers in Brazil, in order to avoid virus transmission through blood donors. 
Objective: This study aimed to evaluate the seroprevalence of HTLV-1/2 in blood donors in 
the State of Maranhão, Brazil, during routine blood unit screening. 
Methods: Screening tests of blood donors using the enzyme-linked immunosorbent assay 
(ELISA) to detect seropositivity for HTLV-1/2 performed at the Hematology and Hemotherapy 
Center of the State of Maranhão (HEMOMAR) between July of 2003 and December of 2009 
were retrospectively evaluated.
Results: Of the 365,564 blood donors, 561 (0.15%) were HTLV-1/2-positive, of whom 72 (12.8%) 
performed the confirmatory test (Western blot). In donors who had a confirmatory test, 53 
(73.6%) were positive. The ages of the infected individuals ranged from 18 to 65 years; 305 
(54%) were aged over 40 years. Among the infected individuals, 309 (55%) were male, 399 
(71%) were mixed-race, and 259 (46%) were single. Co-infections were frequently found, 
especially with hepatitis B (in 68.6% of the cases).
Conclusion: The results obtained will contribute to the planning and implementation of 
control measures by the epidemiological surveillance agency of Maranhão, and will also 
contribute to reducing morbidity. The high seropositivity in a small sample in donors who 
had confirmatory tests indicates the need for confirmatory tests for all donors who initially 
test as seropositive.
© 2014 Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular. 
All rights reserved. 
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Introduction
Although the human T-cell lymphotropic virus (HTLV) was 
only recently discovered, it is recognized as an important 
retroviral agent regarding the damage it inflicts upon humans.1
HTLV type 1 (HTLV-1) has recently been shown to be associ-
ated with severe diseases, such as T-cell leukemia/lymphoma, 
tropical spastic paraparesis, and other inflammatory and infec-
tious diseases.2-4
It is believed that around 15 to 20 million people worldwide 
are infected with HTLV-1, although most of them remain 
asymptomatic.5 In Brazil, the importance of this virus for public 
health was only understood in 1993, when serological screening 
for HTLV-1/2 became mandatory in blood donor candidates.6 
Based on estimates derived from known prevalences, around 
2.5 million people in Brazil may be infected with HTLV-1, which 
makes Brazil the world leader in absolute numbers of cases. 
HTLV-2 is also present within Brazil; its prevalence is very 
significant, especially among the indigenous population.7 
Studies have shown that this virosis is more common in 
Northern and Northeastern Brazil than in Southern Brazil. The 
Quilombo settlements in central Brazil present a prevalence of 
HTLV-1 of 0.5%,8 whereas São Luís, the capital of the State of 
Maranhão, Northeastern Brazil, has a high prevalence rate of 
10:1,000 habitants.9
HTLV transmission between humans is very similar that of 
human immunodeficiency virus (HIV), and differs only in that 
HTLV is less infective. Transmission between humans primarily 
occurs through sexual contact, vertical contact (prolonged 
breastfeeding and through the placenta, during delivery), 
and blood contact (through cellular blood components or the 
sharing of contaminated needles or syringes).10 
The transmission rate through blood and blood derivatives 
is approximately 12%, but the risk that individuals infected 
through blood might develop diseases associated with HTLV 
is low, perhaps due to the long latent period between infection 
and the clinical phase of the disease. Many infected carriers 
die beforehand due to underlying diseases.3
Despite the clinical-epidemiological importance of 
infections acquired at blood banks and the increasing concern 
of the Brazilian Ministry of Health in regard to this, there are 
few studies on HTLV-1/2 in Brazil and practically none in 
Maranhão. 
Given the importance of identifying infected blood 
donors in areas of high prevalence of HTLV-1/2, such as 
São Luís, Maranhão, the present study aimed to estimate 
the seroprevalence of HTLV-1/2 during routine blood unit 
screening at the Centro de Hematologia e Hemoterapia do 
Maranhão (HEMOMAR), and thus contribute to better strategies 
to control and prevent this virosis.
Methods
Study area
The State of Maranhão, with a population of 6,103,327 
inhabitants,11 is served by HEMOMAR, which is located in 
the state capital, São Luís; this center is supported by seven 
specialized blood banks distributed throughout the hinterlands 
of the state. 
Sample acquisition
A cross-sectional study was conducted with a retrospective 
survey of serological tests for HTLV using an enzyme-linked 
immunosorbent assay (ELISA; Murex HTLV-1 + 2, GE 80/81, 
Murex Diagnostics® - Dartford, UK). The tests were performed 
between July of 2003 and December of 2009 to screen blood 
donors at HEMOMAR in São Luís and in the seven blood banks 
in the hinterlands of the state. Thus, the positive sample for 
this study was formed by 561 individuals. 
The data obtained were coded and entered into a database 
using Epi-Info 6 (release 3.04) and Microsoft Office Excel 2010. 
Ethical issues
During the investigative process, the ethical issues regulated 
by Resolution No. 196/96 of the National Health Board and by 
the Declaration of Helsinki of 1964, as revised in 2008, were 
respected. This study was approved by the Research Ethics 
Committees of the Hospital Universitário Presidente Dutra, 
Universidade Federal do Maranhão (UFMA) and HEMOMAR. 
Results
Using the ELISA test, 561 individuals (0.15%) positive for HTLV-
1/2 were identified out of a total of 365,564 donors over the 
period from 2003 to 2009 (Table 1). 
Regarding the spatial distribution of individuals who were 
seropositive for HTLV, it was observed that most came from 
the metropolitan area of São Luís, followed by the cities of 
Imperatriz and Balsas.
Three hundred and nine (55%) individuals positive for HTLV 
were male. The ages ranged from 18 to 65 years; 305 (54%) 
were aged 40 years or older (Table 2). It was also observed that 
259 (46%) were single and 204 (36%) were married. Regarding 
self-declared racial background, 399 (71%) were mixed-race, 39 
(6.9%) were white, 38 (6.7%) were black, 15 (2.6%) were native 
Brazilians, one (0.1%) was East Asian, and two (0.3%) were of 
unidentified racial type. 
Variable Blood donors Seropositive
2003 43,917 86
2004 45,398 80
2005 52,325 74
2006 48,725 54
2007 54,051 72
2008 60,590 98
2009 60,558 97
Total 365,564 561
Table 1 - Positive results for HTLV-1/2 among blood 
donors at a blood center in the State of Maranhão 
between 2003 and 2009.
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African slave trade during Portuguese colonization, mostly to 
the Southeast and Northeast of Brazil. Furthermore, there is a 
clear positive ecological correlation (high relative humidity and 
temperature) with the higher HTLV-1/2 seroprevalence rates 
among blood donors in these regions of the country.9
Regarding gender, most positive cases were males. This 
was also observed in other studies,6,13,15 with prevalences 
among males of 54.95%, 59.4%, and 57.8%. However, this is 
usually explained by the higher numbers of male donors 
than female donors. Colin et al.5 considered that gender was 
not only a biological variable, but also a cultural, social, and 
economic variable, with multiple effects, associations, and 
even confounding bias.
Regarding age, 54% of the individuals were over the age of 
40 years; this finding is similar to those of Mota et al.,12 who 
reported that 50.55% of the seropositive individuals were 40 
years or over, and of Monteiro de Castro et al.,15 who observed 
greater seropositivity among individuals over the age of 40 
years. Veit et al.16 observed that 89.47% of the seropositive 
blood donors were over the age of 34 years.
Regarding the spatial distribution of individuals who were 
seropositive for HTLV, it was observed that most seropositive 
individuals were from the metropolitan area of São Luís, 
followed by the cities of Imperatriz and Balsas. These two 
cities were developed because of timber and soybeans, 
respectively, and present intense migratory flows. This leads 
to the hypothesis that economic and social development may 
be associated with HTLV transmission. 
Regarding the clinical development of the cases of HTLV-1, 
the present study included the aforementioned case of tropical 
spastic paraparesis associated with Arnould-Chiari syndrome 
and syringomyelia. This case has already been the subject of 
another article published by this group.17
Conclusion
The results from the present study demonstrate that there 
is a need for greater sanitary education among mixed-race, 
male, and single individuals, as well as those over 40 years 
of age, which should be the target group for planning control 
strategies by municipal and state epidemiological surveillance 
2003 2004 2005 2006 2007 2008 2009
Male Female Male Women Male Female Male Female Male Female Male Female Male Female
Age range n (%) n (%) n (%) n (%) n (%) n (%) n (%) n (%) n (%) n (%) n (%) n (%) n (%) n (%)
18-29 3 (3.5) 0 (0.0) 5 (6.2) 1 (1.2) 8 (10.8) 4 (5.4) 4 (7.4) 2 (3.7) 11 (15.2) 7 (9.7) 14 (14.3) 11 (11.2) 19 (19.6) 7 (7.2)
30-39 20 (23.3) 11 (12.8) 17 (21.3) 9 (11.3) 11 (14.9) 7 (9.4) 9 (16.6) 9 (16.6) 8 (11.1) 6 (8.3) 16 (16.3) 10 (10.2) 16 (16.6) 11 (11.3)
40-49 18 (20.9) 7 (8.1) 18 (22.5) 10 (12.5) 8 (10.8) 6 (8.1) 9 (16.6) 8 (14.8) 7 (9.7) 8 (11.1) 11 (11.2) 14 (14.3) 11 (11.3) 13 (13.4)
50-65 9 (10.5) 13 (15.1) 6 (7.5) 14 (17.5) 16 (21.6) 12 (16.2) 4 (7.4) 9 (16.6) 12 (16.6) 13 (18.0) 8 (8.2) 14 (14.3) 6 (6.2) 13 (13.4)
> 65 3 (3.5) 2 (2.3) 0 (0.0) 0 (0.0) 1 (1.4) 1 (1.4) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 1 (1.0) 0 (0.0)
Total 86 (100) 80 (100) 74 (100) 54 (100) 72 (100) 98 (100) 97 (100)
Table 2 - Distribution of blood donors who were serologically positive for HTLV-1/2 according to age group and gender 
in the State of Maranhão, 2003 to 2009.
Of the 561 seropositive individuals according to the 
ELISA test, only 72 (12.8%) performed the confirmatory test 
(Western blot), as the state of Maranhão does not provide the 
examination through the Brazilian Unified Health System 
(Sistema Único de Saúde - SUS). Of the donors who performed 
a confirmatory test, 53 (73.6%) were positive.
Between 2003 and 2007, 172 patients from a total of 244,416 
blood donors presented associations with hepatitis B (HBV 
- 118; 68.6%), hepatitis C (HCV - 9; 5.2%), syphilis (8; 4.6%), 
and HIV (4; 2.3%). It was also observed that 16 patients (9.3%) 
were positive for HTLV, HBV, and syphilis, and another eight 
patients (4.6%) were positive for HTLV, HBV, and HCV.
Three patients (0.5%) had had over ten sexual partners, 
and especially, there was one patient (0.1%) who had had 
more than 50 (SIC) for occupational reasons. One patient also 
presented Arnold-Chiari syndrome and syringomyelia, with 
abnormalities of distal weakening of the upper limbs and 
proximal weakening of the lower limbs (grade 3 on the motor 
scale), spasticity in the distal lower limbs, right-side patellar 
hyporeflexia and left-side hyperreflexia, hyperreflexia of the 
Achilles tendon on both sides, and Babinsky’s sign on both 
sides, in neurological examinations, along with a neurogenic 
bladder.
Discussion
In the present study, the prevalence of positive ELISA tests 
for HTLV-1/2 was approximately 0.15%. Salles et al.12 found 
similar values in 1998, 1999, 2000, and 2001, at the Pró-Sangue 
Foundation Hemocenter, São Paulo: 0.20%, 0.20%, 0.30%, and 
0.10%, respectively. At HEMOACRE, a value of 0.11% was 
observed using the same kit (Elisa Murex®), and values ranging 
from 0.08% to 1.80% were found between 1989 and 1996, which 
were also within the national average.7 At HEMOMINAS, 
a value of 0.1% was observed between 1993 and 2007 using 
ELISA.13 At Hemonúcleo de Patos, in the state of Paraíba, Braga 
et al.14 found a prevalence of 0.025% of HTLV-1 between 2002 
and 2011. The higher prevalence in the current study may be 
justified by population migration in prehistoric times from 
Asia through North America, reaching what are now the North 
and Northeast regions of Brazil first. Another possibility is the 
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agencies, in order to reduce the morbidity caused by this virus. 
The high seropositivity in such a small sample of donors who 
had a confirmatory test (Western blot) indicates the need for 
confirmatory tests in all individuals identified as seropositive 
during screening.
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